Blocking A Neuropeptide Receptor Decreases Nicotine Addiction

The study was published in an online Early Edition issue of the Proceedings of the National Academy of Sciences, the week of November 24. Scripps Florida is a division of The Scripps Research Institute. The neuropeptide, hypocretin-1 (Orexin A), may initiate a key signaling cascade, a series of closely linked biochemical reactions, which maintains tobacco addiction in human smokers and could be a potential target for developing new smoking cessation treatments.

More: continued here

Filed under: Alcohol / Addiction / Illegal Drugs on November 25th, 2008